284 related articles for article (PubMed ID: 20733279)
1. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
2. Predicting Survival of Small Intestine Neuroendocrine Tumors: Experience From a Major Referral Center.
Kelly S; Aalberg J; Agathis A; Phillips K; Haile S; Haines K; Kang Kim M; Divino CM
Pancreas; 2019 Apr; 48(4):514-518. PubMed ID: 30946234
[TBL] [Abstract][Full Text] [Related]
3. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal neuroendocrine tumors: prognostic factors and survival.
Bergestuen DS; Aabakken L; Holm K; Vatn M; Thiis-Evensen E
Scand J Gastroenterol; 2009; 44(9):1084-91. PubMed ID: 19572232
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for terminally ill cancer patients.
Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
[TBL] [Abstract][Full Text] [Related]
6. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
7. A Predictive Nomogram for Small Intestine Neuroendocrine Tumors.
Kelly S; Aalberg J; Kim MK; Divino CM
Pancreas; 2020 Apr; 49(4):524-528. PubMed ID: 32282765
[TBL] [Abstract][Full Text] [Related]
8. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
Klatte T; Remzi M; Zigeuner RE; Mannweiler S; Said JW; Kabbinavar FF; Haitel A; Waldert M; de Martino M; Marberger M; Belldegrun AS; Pantuck AJ
J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
[TBL] [Abstract][Full Text] [Related]
9. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
[TBL] [Abstract][Full Text] [Related]
10. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
[TBL] [Abstract][Full Text] [Related]
11. Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy.
Gustafsson BI; Siddique L; Chan A; Dong M; Drozdov I; Kidd M; Modlin IM
Int J Oncol; 2008 Dec; 33(6):1121-31. PubMed ID: 19020744
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
Chi DS; Palayekar MJ; Sonoda Y; Abu-Rustum NR; Awtrey CS; Huh J; Eisenhauer EL; Barakat RR; Kattan MW
Gynecol Oncol; 2008 Jan; 108(1):191-4. PubMed ID: 17950784
[TBL] [Abstract][Full Text] [Related]
13. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients.
Landry CS; Brock G; Scoggins CR; McMasters KM; Martin RC
Am J Surg; 2008 Dec; 196(6):896-903; discussion 903. PubMed ID: 19095106
[TBL] [Abstract][Full Text] [Related]
14. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
Mariani L; Miceli R; Kattan MW; Brennan MF; Colecchia M; Fiore M; Casali PG; Gronchi A
Cancer; 2005 Jan; 103(2):402-8. PubMed ID: 15578681
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
[TBL] [Abstract][Full Text] [Related]
17. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
[TBL] [Abstract][Full Text] [Related]
18. Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.
Gaur P; Leary C; Yao JC
Ann Surg; 2010 Jun; 251(6):1117-21. PubMed ID: 20485130
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
20. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]